Cvs Health (CVS) Cost of Revenue (2009 - 2026)

Cvs Health (CVS) has 18 years of Cost of Revenue data on file, last reported at $10.9 billion in Q1 2026.

• Quarterly Cost of Revenue fell 78.57% year-over-year to $10.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $158.4 billion (down 48.26% YoY) and the FY2025 annual result came in at $221.2 billion, up 7.21% from the prior year.
• Cost of Revenue declined to $10.9 billion in Q1 2026, from $59.1 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $175.1 billion in Q4 2024 to a low of -$47.6 billion in Q4 2022.
• A 5-year average of $39.4 billion and a median of $31.3 billion in 2025 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2024 — Cost of Revenue jumped 677.61% — and 2026, when it sank 78.57%.
• Tracing CVS's Cost of Revenue over 5 years: stood at -$47.6 billion in 2022, then surged by 147.34% to $22.5 billion in 2023, then jumped by 677.61% to $175.1 billion in 2024, then sank by 66.27% to $59.1 billion in 2025, then sank by 81.47% to $10.9 billion in 2026.
• The last three Cost of Revenue figures came in at $10.9 billion (Q1 2026), $59.1 billion (Q4 2025), and $57.0 billion (Q3 2025), per Business Quant data.